TITLE

SIX YEARS OF PRESSURE-GRADIENT THERAPY

AUTHOR(S)
Beninson, Joseph
PUB. DATE
January 1961
SOURCE
Angiology;Jan1961, Vol. 12 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recalls the author's experience in applying pressure-gradient therapy for leg ulcers. Superiority of the new method over other known therapies for the disease; Citation of a case in which a patient was successfully treated with the method; Emphasis on the importance of maintaining the healed state through out the therapy.
ACCESSION #
16397131

 

Related Articles

  • Optimum treatment of venous leg ulcers.  // Practice Nurse;Oct2005 Supplement, p12 

    This article discusses the optimum treatment of venous leg ulcers. Vascular disease and in particular venous disease, accounts for 70-85% of lower limb ulcers. Venous leg ulcers are common, often chronic and debilitating and can substantially impair patients' quality of life and work...

  • Pathophysiology of Venous Leg Ulceration--An Update. Dormandy, John A. // Angiology;Jan1997, Vol. 48 Issue 1, p71 

    The microcirculatory component of the pathophysiology of venous ulceration is now attracting considerable research interests, but is still far from fully elucidated. Currently, the central role is filled by the inappropriately activated white cell and its interaction with the endothelium....

  • Larval therapy vs hydrogel for leg ulcers: similar benefits, costs.  // PharmacoEconomics & Outcomes News;4/4/2009, Issue 575, p7 

    The article discusses a cost effective analysis of larval therapy for leg ulcers. It showed that the debridement of leg ulcers with larval therapy may produce health benefits similar to treatment with hydrogel matrix. In addition, larval therapy costs £96.70 more per patient per year than...

  • How to measure success in treating chronic leg ulcers. Grey, Joseph E.; Leaper, David; Harding, Keith // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/2/2009, Vol. 338 Issue 7702, p1021 

    The authors reflect on the measurement of success in treatments that are used with chronic leg ulcers. They suggest that healing is not the only desirable outcome measure that is associated with chronic leg ulcers. They argue that instead of focusing on healing as the only measure of success, it...

  • The care of VENOUS LEG ULCERS. Benbow, Maureen // Practice Nurse;7/29/2005, Vol. 30 Issue 2, p10 

    Discusses the treatment of venous leg ulcers. Rationale behind the prevalence of ulceration in older women; Factors that affect the development of venous leg ulcers; Application of the Doppler assessment method.

  • Developing a multidisciplinary leg ulcer clinic across two trusts. Speding, Irene // British Journal of Community Nursing;Dec2008 Supplement, Vol. 13, pS31 

    This article takes a retrospective look at modernizing treatment of patients with leg ulceration, moving them out of busy treatment rooms and into designated leg ulcer clinics offering holistic care from nurses who are trained in the core areas of: care plan assessment, Doppler assessment,...

  • The relationship between pain and leg ulcers: a critical review. McMullen, Marie // British Journal of Nursing;10/28/2004, Vol. 13 Issue 19, pS30 

    Leg ulceration may have a profound impact on the individual: in some cases activities of living become subservient to the degree of pain experienced. Pain control, which is viewed as a key function in health care, appears marginalized in leg ulcer management. Pain can be intense, bringing...

  • Socioeconomic Impact of Chronic Venous Insufficiency and Leg Ulcers. Ruckley, C. V. // Angiology;Jan1997, Vol. 48 Issue 1, p67 

    Chronic venous insufficiency affects approximately 5% and chronic leg ulcer approximately 1% of the adult population of developed countries. Not only do recent quality of life studies highlight major disability and social impairment but, since this is a condition characterized by chronicity and...

  • Efficacy of Daflon 500 mg in Venous Leg Ulcer Healing: A Double-Blind, Randomized, Controlled Versus Placebo Trial in 107 Patients. Guilhou, Jean-Jacques; Dereure, Olivier; Marzin, Loïc; Ouvry, Pierre; Zuccarelli, François; Debure, Clélia; van Landuyt, Hervé; Gillet-Terver, Marie-Noélle; Guillot, Bernard; Levesque, Hervé; Mignot, Jean; Pillion, Gérard; Février, Benoit; Dubeaux, Dominique // Angiology;Jan1997, Vol. 48 Issue 1, p77 

    The objective of this study was to evaluate the efficacy of Daflon® 500 mg (Dios)* in venous ulcers. A multicenter, double-blind, randomized, controlled versus placebo (Plac) trial was conducted, with stratification according to the size of ulcer (⩽ 10 cm and > 10 cm). The protocol...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics